VCRE Stock Chart & Stats
$11.59
-$0.32(-2.81%)
At close: 4:00 PM EDT
$11.59
-$0.32(-2.81%)
Day’s Range― - ―
52-Week Range$10.47 - $17.80
Previous Close$11.06
Volume1.11K
Average Volume (3M)7.38K
Market Cap
$330.88M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta2.72
Next Earnings
Nov 05, 2026EPS Estimate
-0.53Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.54
Shares Outstanding28,152,560
10 Day Avg. Volume8,945
30 Day Avg. Volume7,377
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
VCRE FAQ
What was Vicore Pharma Holding AB Sponsored ADR’s price range in the past 12 months?
Vicore Pharma Holding AB Sponsored ADR lowest stock price was $10.47 and its highest was $17.80 in the past 12 months.
What is Vicore Pharma Holding AB Sponsored ADR’s market cap?
Vicore Pharma Holding AB Sponsored ADR’s market cap is $330.88M.
When is Vicore Pharma Holding AB Sponsored ADR’s upcoming earnings report date?
Vicore Pharma Holding AB Sponsored ADR’s upcoming earnings report date is Nov 05, 2026 which is in 54 days.
How were Vicore Pharma Holding AB Sponsored ADR’s earnings last quarter?
Vicore Pharma Holding AB Sponsored ADR released its earnings results on Aug 21, 2026. The company reported -$0.539 earnings per share for the quarter, missing the consensus estimate of -$0.422 by -$0.117.
Is Vicore Pharma Holding AB Sponsored ADR overvalued?
According to Wall Street analysts Vicore Pharma Holding AB Sponsored ADR’s price is currently Overvalued.
Does Vicore Pharma Holding AB Sponsored ADR pay dividends?
Vicore Pharma Holding AB Sponsored ADR does not currently pay dividends.
What is Vicore Pharma Holding AB Sponsored ADR’s EPS estimate?
Vicore Pharma Holding AB Sponsored ADR’s EPS estimate is -0.53.
How many shares outstanding does Vicore Pharma Holding AB Sponsored ADR have?
Vicore Pharma Holding AB Sponsored ADR has 28,152,560 shares outstanding.
What happened to Vicore Pharma Holding AB Sponsored ADR’s price movement after its last earnings report?
Vicore Pharma Holding AB Sponsored ADR reported an EPS of -$0.539 in its last earnings report, missing expectations of -$0.422. Following the earnings report the stock price went up 7.759%.
Which hedge fund is a major shareholder of Vicore Pharma Holding AB Sponsored ADR?
Currently, no hedge funds are holding shares in VCRE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Vicore Pharma Holding AB Sponsored ADR Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-6.23%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Vicore Pharma Holding AB Sponsored ADR
Vicore Pharma Holding AB is a pharmaceutical company, which engages in the development of drugs with focus on interstitial lung diseases and related indications. Its drug development programs include VP01, VP02, VP03, and VP04. The company was founded in 2000 sand is headquartered in Stockholm, Sweden.